Peer Review History
| Original SubmissionMay 18, 2020 |
|---|
|
PONE-D-20-14860 Retrospective development of a novel resilience indicator using existing cohort data: the adolescent to adult health resilience instrument PLOS ONE Dear Dr. Montoya-Williams, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please respond to the two reviews point by point. You will see that most of the issues the reviewers raise are concerned with clarifications and additional detail on the methods, sample, study design, and results of the study. Both reviewers would like to see a more comprehensive and critical review of the literature on resilience. I would add that you should focus this review on measures of resilience for adolescent and young adult populations. Please submit your revised manuscript by Oct 19 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Ellen L. Idler Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 3. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Introduction Please critically review previous instruments used to assess resilience. Please add 21 candidate Add Health items that were evaluated for inclusion in AHRI as a supplement file. Which method of factor rotation was used, why did you use this method, please add explanation into method section? Direct Oblimin Method? Promax Rotation? The Methods section should be written as concisely as possible but should contain all elements necessary to allow interpretation and replication of the results. Such a sub titles something like these are recommended The items & instruments Study Samples (brief explanation about sampling in the fourth wave of original research) Statistical analysis, Exploratory factor analysis, Known group comparison (construct validity), Reliability, Ethics Please explain, is the scale is a screening one or a detective? Is there a cut-off point score for the scale? Table 2, the last column is somewhat confusing. Did you indicate the alpha values for the scale if item deleted? The alpha level of factor 3 is not satisfactory. What is the researcher explanation for such an alpha level? Aren’t the data from 2008 too old to be presented as an original research? Reviewer #2: 1. Is the manuscript technically sound, and do the data support the conclusions? The proposed AHRI can be a useful tool for researchers working with the Add Health study. The manuscript is reasonably sound, and the evidence seems to support the conclusions the authors present. However, some technical matters require more attention and discussion. I base the following six observations and recommendations on my comparison of the manuscript content with desiderata for factor analysis listed in page 94 of Bandalos’s and Finney’s 2010 “Factor Analysis: Exploratory and Confirmatory,” in Hancock’s and Mueller’s (editors) The Reviewer’s Guide to Quantitative Methods in the Social Sciences, published by Routledge. 1. The authors introduce the concept of resilience only very briefly. Although they mention typically used components of the latent construct, a fuller discussion of the theory behind or conceptual understanding of this construct would be helpful. For example, in the Discussion section, the authors mention that there is an ongoing debate about the best way to understand resilience: as a presumably fixed personality trait, as a behavioral outcome, or as a dynamic process. It stands to reason that the use of the concept may vary depending on different research questions, so the authors should make clear those research questions and the conceptual understanding or theory that links the concept of resilience to upstream predecessors or downstream outcomes. Making the conceptual understanding of resilience explicit will also help evaluate how well the candidate and selected Add Health items operationalize the concept. 2. Authors should indicate whether their factor analysis is exploratory or confirmatory (EFA, or CFA) and justify their decision, as each type of analysis serves a different purpose. The general guidance is to use the first type for newly developed constructs or when the theoretical basis is weak and to use CFA when the structure of the variable is well-established, as when using an independent sample to test a well-studied structure. 3. The authors should also indicate whether any of the variables selected as candidates for the factor analysis are not continuous. If so, they should note whether the variables are dichotomous or scales with less than five points. Such items may result in biased solutions and require a different type of analysis. Authors should identify all items, and including the variables’ codes will be helpful to researchers who wish to adopt the new instrument presented in this research paper. Also, the authors could have discussed whether the candidate items provide good-enough coverage of the dimensions of the latent concept. A table of the CD-RISC’s items, organized by domain, with the corresponding Add Health items lined up would be beneficial and illustrate whether any domains from the CD-RISC cannot be operationalized. 4. A discussion of the size of the analytical sample is missing: over 35 percent of the Wave IV sample was lost. Did one or a few items result in this loss of observations? If so, how does this affect the operationalization of the latent concept? Were non-responses concentrated among certain age, gender, racial or ethnic groups? If so, what impact does that have on the applicability of the proposed AHRI? 5. Difficulty factors that lead to misleading factor solutions may arise when variables with similar skewness and kurtosis can result in artefactual factors. To rule this out, or identify such factors, the authors should provide a summary of the candidate item’s descriptive statistics (mean, standard deviation, and values of skewness and kurtosis). Perhaps the table I proposed above can include CD-RISC items first, the corresponding candidate ASRI items next, then the percent missing responses for each item, and the descriptive statistics last. 6. I expected some discussion of the dimensionality of the chosen solution. The authors indicated that the CD-RISC operationalizes five domains, but the AHRI only has three. For example, the authors excluded the religiosity items from the selected solution, so the proposed AHRI does not operationalize the domain of spiritual influences. Is this not an important limitation of the proposed AHRI? Can the religiosity items from Add Health be retained to provide coverage for that domain, balancing a fuller operationalization with a weaker mathematical solution? What is the other domain not covered in the chosen solution, and can alternative solutions solve this? The following seven observations concern my reading of the Methodology and Results sections: 7. I am not familiar with the evaluation of convergent validity. Based on its description (line 154 on), it seems to consist in evaluating the proposed AHRI through its correlation with a validated scale for depression, the CESD-10, which is empirically associated with extant resilience scales. I would appreciate a brief description of justification for this type of validation. Am I correct in thinking it consists of logically inverting the independent variable (resilience, which is theoretically upstream from the outcome of depression) with the dependent variable? 8. The second factor in the chosen factor solution, “Social Support / Feeling Overwhelmed,” is problematic. Having good social support and feeling overwhelmed strike me as related by not necessarily covarying concepts. A person who perceives the support of friends and family may feel overwhelmed by particularly stressful situations or traumatic events, while a person without support may feel overwhelmed more frequently. 9. I appreciated the analysis of average resilience scores for different demographic groups on page 11. However, given that some of the participants in the Add Health study may not have completed college, become financially independent, or had time to establish themselves in their careers *yet*, the comparisons by educational attainment and household income may not be the most meaningful. 10. Finally, I may be misinterpreting information on Tables 4 and 5 (on pages 11 and 12), but it seems that the confidence intervals for the scores of some of the comparison groups overlap. For example, at the top of Table 4, the mean AHRI score for Female is 13.8 with SD of 5.0, so the 95% confidence interval would run from around 3.8 to 23.8, roughly speaking, and would overlap the mean for Male, which is 14.4. Therefore, the means for Female and Male are not significantly different at the 95% confidence level, let alone at the 99.9% level. 2. Has the statistical analysis been performed appropriately and rigorously? Yes, it has. However, as indicated above, some of the decisions the authors made require more discussion. 3. Have the authors made all data underlying the findings in their manuscript fully available? No, the authors are contractually barred from sharing the restricted-use data from the Add Health study. However, Add Health makes a probability sample from the same wave the authors used available for public use. Confirming the results of the author’s analysis should be possible with that data. 4. Is the manuscript presented in an intelligible fashion and written in standard English? Yes, but the authors should proofread for punctuation errors. They can also tighten the structure of the narrative to better guide the reader through their work. Specific suggestions: 1. Some necessary commas are missing. For example, as written in line 116, the last domain of the CD-RISC seems to be, “control and spiritual influences,” when these are two distinct domains. I recommend the use of the Oxford comma, which adds clarity in lists. The authors may consider revising their manuscript to avoid using the passive voice, although this may be a field-specific preference. 2. I recommend the authors use the full name of the Add Health study in the first mention: National Longitudinal Study of Adolescent to Adult Health. The authors may be more familiar with cohort studies and retrospective analyses, but I consider it is more accurate to describe Add Health as a longitudinal study and to describe the author’s work as a cross-sectional analysis. It seems to be that a retrospective analysis would require predicting outcomes in Wave 4 (the wave from which the authors drew data) using independent variables from one of the earlier waves, but that is not the case. It would also be preferable if the authors distinguished the terms study and dataset (Add Health is a study, and several datasets are available for the various questionnaires that make up the study.) It is important to note that Add Health participants should not be described as patients, as being a patient was not a selection for inclusion. 3. Wave IV, conducted in 2008, is not the Add Health study’s original wave of data collection (line 155). 4. The description of the resilience scale developed by Hitlin and Elder previously belongs in the Introduction, together with other extant evidence is presented, rather than appearing towards the end of the paper. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Marzieh Araban Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Retrospective development of a novel resilience indicator using existing cohort data: the Adolescent to Adult Health Resilience Instrument PONE-D-20-14860R1 Dear Dr. Montoya-Williams, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Your attention to reviewers' comments and your revision were careful and thorough. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ellen L. Idler Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: This is carefully conducted and well explained research that is interesting work in its own right. It may also serve as a methodological example for other researchers who need to adapted existing existing psychometric scales to the Add Health study and then validated the adapted scales. Thanks for addressing the comments from the first review; I hope some of them were helpful. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-14860R1 Retrospective Development of a Novel Resilience Indicator using Existing Cohort Data: The Adolescent to Adult Health Resilience Instrument Dear Dr. Montoya-Williams: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Ellen L. Idler Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .